Transplantation, HomologousHematopoietic Stem Cell TransplantationBusulfanStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTissue DonorsTransplantation ChimeraTreatment OutcomeGraft SurvivalGraft vs Tumor EffectStem CellsMyeloablative AgonistsRecurrenceRemission InductionHistocompatibility TestingGraft vs Leukemia EffectVidarabineLeukemiaSurvival RateWhole-Body IrradiationLeukemia, Myeloid, AcuteDisease-Free SurvivalImmunosuppressive AgentsRetrospective StudiesSurvival AnalysisCombined Modality TherapyMultiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionTime FactorsCytomegalovirus InfectionsCord Blood Stem Cell TransplantationSiblingsHistocompatibilityHematopoietic Stem CellsAntilymphocyte SerumMyelodysplastic SyndromesKidney TransplantationSalvage TherapyMinor Histocompatibility AntigensLymphocyte DepletionHepatic Veno-Occlusive DiseaseCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationMelphalanNeoplasm, ResidualVirus ActivationAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesChimerismGraft RejectionFollow-Up StudiesCytomegalovirusAcute DiseaseGranulocyte Colony-Stimulating FactorAnemia, AplasticHematopoietic Stem Cell MobilizationMesenchymal Stem Cell TransplantationHLA AntigensImmunosuppressionPrimary MyelofibrosisPrognosisHematologic DiseasesTransplantation ImmunologyCell TransplantationLeukemia, Myeloid, Accelerated PhaseLeukemia, MyeloidHeart TransplantationAntigens, CD34CyclosporineImmunocompromised HostCytarabineAntineoplastic AgentsEmbryonic Stem CellsAntibodies, NeoplasmLymphoproliferative DisordersTransplantation, IsogeneicBenzamidesRoseolovirus InfectionsInfectionFusion Proteins, bcr-ablAdult Stem CellsHodgkin DiseaseGanciclovirLymphoma, Non-HodgkinLung TransplantationLiving DonorsNuclear FamilyPyrimidinesCell SurvivalReceptors, Purinergic P2X5Fatal OutcomeOpportunistic InfectionsProspective Studies